Pharmacological Treatment of Comorbid Alcohol and Marijuana Withdrawal and Dependence

Completed · Phase 2 · Has a placebo group

Conditions studied: Cannabis Dependence, Alcohol Dependence, Cannabis Use Disorder, Alcohol Use Disorder

In brief

The primary aim of the supplemental study is to provide POC testing of aprepitant as a treatment for comorbid alcohol and cannabis dependence. The data analysis plan specified in the parent grant will likewise be applied to the supplemental project to test for effects of aprepitant vs placebo on measures of alcohol and cannabis use and protracted withdrawal. The primary hypothesis is that subjects treated with aprepitant will have significantly less alcohol and marijuana use than subjects treated with placebo.

Key facts

Study ID
NCT02210195
Run by
The Scripps Research Institute
People needed
20
Starts
2014-09-04
Expected to finish
2016-12-19
Last updated by the study team
2017-08-02

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.